EUVIMEDEUVIMED entdecken
Vergleichsstudie

1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions

Tadao Aikawa, Kyohei Yamaji, Toshiki Kuno, Shun Kohsaka, Hideki Ishii, Yuya Matsue, Kazunori Omote, Naohiro Funayama, Kazuyuki Ozaki, Hiroyuki Kunii, Tetsuya Amano, Tohru Minamino und 1 weitere

JACC: Cardiovascular Interventions · 2026

DOI: 10.1016/j.jcin.2026.06.023 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2026. Verfasst von Tadao Aikawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Cardiology, Hokkaido …. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Coronary Artery Bypass, Coated Materials, Biocompatible. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Terumo Foundation for Life Sciences and Arts, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Graft failure after coronary artery bypass grafting is a common clinical problem associated with adverse cardiovascular outcomes. Although percutaneous coronary intervention (PCI) for bypass graft lesions is frequently performed, the optimal device strategy remains debated. Recently, drug-coated balloon (DCB) has emerged as a stentless alternative. OBJECTIVES: This study aimed to compare 1-year clinical outcomes between drug-eluting stent (DES) and DCB-only strategies in patients undergoing PCI for bypass graft lesions. METHODS: We analyzed data from the J-PCI OUTCOME (Japanese Percutaneous Coronary Intervention Outcome Registry), a nationwide registry in Japan. Patients who underwent PCI with DES or stentless PCI with DCB for bypass graft lesions between 2017 and 2020 were included. The primary endpoint was major adverse cardiovascular events (MACEs), defined as a composite of all-cause death, acute coronary syndrome, and stroke within 1 year after PCI. Secondary endpoints included individual components of MACE, major bleeding, and planned repeat revascularization. RESULTS: Of the 610 PCIs for bypass graft lesions, 184 (30.2%) were stentless PCIs with DCB. One-year MACE rates did not differ significantly between the DES and DCB-only strategies (10.3% vs 8.6%; P = 0.69). No statistically significant differences were observed in the secondary endpoints. After multivariable adjustment, the DCB-only strategy was not associated with a significant difference in MACE risk after PCI compared with the DES-based strategy (adjusted HR: 1.01; 95% CI: 0.58-1.76; P = 0.96). CONCLUSIONS: Stentless PCI with DCB was frequently used in patients undergoing PCI for bypass graft lesions in Japan and was not associated with a significant difference in 1-year clinical outcomes compared with contemporary DES-based PCI strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsAngioplasty, Balloon, CoronaryCoronary Artery BypassCoated Materials, BiocompatibleGraft Occlusion, VascularCoronary Artery DiseaseCardiac CathetersHumansTime FactorsTreatment OutcomeRegistriesJapanRisk FactorsAgedFemaleMaleProsthesis DesignRisk AssessmentMiddle Aged

Stichwörter der Autor:innen

coronary artery bypass graft failuredrug-coated balloon angioplastydrug-eluting stent(s)major adverse cardiovascular event(s)

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Cardiology, Hokkaido Cardiovascular Hospital, Sapporo, Japan. Electronic address: tadao.aik…
  • Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan.
  • Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Förderung

  • Terumo Foundation for Life Sciences and Arts
  • Japan Society for the Promotion of Science

Zitieren

APA

Aikawa, T., Yamaji, K., Kuno, T., Kohsaka, S., Ishii, H., Matsue, Y., Omote, K., Funayama, N., Ozaki, K., Kunii, H., Amano, T., Minamino, T., & Kozuma, K. (2026). 1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2026.06.023

Vancouver

Aikawa T, Yamaji K, Kuno T, Kohsaka S, Ishii H, Matsue Y, et al. 1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2026.06.023

BibTeX
@article{Aikawa2026,
  author = {Aikawa, Tadao and Yamaji, Kyohei and Kuno, Toshiki and Kohsaka, Shun and Ishii, Hideki and Matsue, Yuya and Omote, Kazunori and Funayama, Naohiro and Ozaki, Kazuyuki and Kunii, Hiroyuki and Amano, Tetsuya and Minamino, Tohru and Kozuma, Ken},
  title = {1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1016/j.jcin.2026.06.023}
}
Kostenlos starten →